The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor - PubMed (original) (raw)
. 1996 Apr 15;15(8):1914-23.
Affiliations
- PMID: 8617238
- PMCID: PMC450110
The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor
R Beyaert et al. EMBO J. 1996.
Abstract
Tumour necrosis factor (TNF) is a pleiotropic cytokine, the activities of which include effects on gene expression, cell growth and cell death. The biological signalling mechanisms which are responsible for these TNF effects remain largely unknown. Here we demonstrate that the stress-responsive p38 mitogen-activated protein (MAP) kinase is involved in TNF-induced cytokine expression. TNF Treatment of cell activated the p38 MAP kinase pathway, as revealed by increased phosphorylation of p38 MAP kinase itself, activation of the substrate protein MAPKAP kinase-2, and culminating in the phosphorylation of the heat shock protein 27 (hsp27). Pretreatment of cells with the highly specific p38 MAP kinase inhibitor SB203580 completely blocked this TNF-induced activation of MAPKAP kinase-2 and hsp27 phosphorylation. Under the same conditions, SB203580 also completely inhibited TNF-induced synthesis of interleukin (IL)-6 and expression of a reporter gene that was driven by a minimal promoter containing two NF-Kappa B elements. However, neither TNF-induced DNA binding of TNF-Kappa B nor TNF-induced phosphorylation of its subunits was modulated by SB203580, suggesting that NF-Kappa B is not a direct target for the p38 MAP kinase pathway. Interestingly, TNF-induced cytotoxicity was not affected by SB203580, indicating that p38 MAP kinase might be an interesting target to interfere selectively with TNF-induced gene activation.
Similar articles
- p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level.
Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, Sluiter W. Pietersma A, et al. Biochem Biophys Res Commun. 1997 Jan 3;230(1):44-8. doi: 10.1006/bbrc.1996.5886. Biochem Biophys Res Commun. 1997. PMID: 9020057 - Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T, Eguchi S, Matsumoto T, Yamakawa Y, Numaguchi K, Miyata I, Reynolds CM, Motley ED, Inagami T. Yamakawa T, et al. Endocrinology. 1999 Aug;140(8):3562-72. doi: 10.1210/endo.140.8.6914. Endocrinology. 1999. PMID: 10433212 - The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K, De Valck D, Vanden Berghe W, Van Criekinge W, Contreras R, Fiers W, Haegeman G, Beyaert R. Heyninck K, et al. J Cell Biol. 1999 Jun 28;145(7):1471-82. doi: 10.1083/jcb.145.7.1471. J Cell Biol. 1999. PMID: 10385526 Free PMC article. - Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2.
Ben-Levy R, Hooper S, Wilson R, Paterson HF, Marshall CJ. Ben-Levy R, et al. Curr Biol. 1998 Sep 24;8(19):1049-57. doi: 10.1016/s0960-9822(98)70442-7. Curr Biol. 1998. PMID: 9768359 Review. - Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases.
Salituro FG, Germann UA, Wilson KP, Bemis GW, Fox T, Su MS. Salituro FG, et al. Curr Med Chem. 1999 Sep;6(9):807-23. Curr Med Chem. 1999. PMID: 10495353 Review.
Cited by
- ZFP36L1 and ZFP36L2 reduce cyclin D1 expression by decreasing expression of E2F1 and long 3'UTR isoform of CCND1 transcripts.
Chan TS, Lee KL, Hung CS, Chiang HP, Chung CC, Liang YC. Chan TS, et al. Mol Cell Biochem. 2024 Aug 7. doi: 10.1007/s11010-024-05087-w. Online ahead of print. Mol Cell Biochem. 2024. PMID: 39110278 - Reduced mammalian target of rapamycin activity facilitates mitochondrial retrograde signaling and increases life span in normal human fibroblasts.
Lerner C, Bitto A, Pulliam D, Nacarelli T, Konigsberg M, Van Remmen H, Torres C, Sell C. Lerner C, et al. Aging Cell. 2013 Dec;12(6):966-77. doi: 10.1111/acel.12122. Epub 2013 Jul 30. Aging Cell. 2013. PMID: 23795962 Free PMC article. - Inhibition of RIP2/RIck/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK.
Argast GM, Fausto N, Campbell JS. Argast GM, et al. Mol Cell Biochem. 2005 Jan;268(1-2):129-40. doi: 10.1007/s11010-005-3701-0. Mol Cell Biochem. 2005. PMID: 15724446 - CD44 is a determinant of inflammatory bone loss.
Hayer S, Steiner G, Görtz B, Reiter E, Tohidast-Akrad M, Amling M, Hoffmann O, Redlich K, Zwerina J, Skriner K, Hilberg F, Wagner EF, Smolen JS, Schett G. Hayer S, et al. J Exp Med. 2005 Mar 21;201(6):903-14. doi: 10.1084/jem.20040852. J Exp Med. 2005. PMID: 15781582 Free PMC article. - Induction of the gene encoding macrophage chemoattractant protein 1 by Orientia tsutsugamushi in human endothelial cells involves activation of transcription factor activator protein 1.
Cho NH, Seong SY, Huh MS, Kim NH, Choi MS, Kim IS. Cho NH, et al. Infect Immun. 2002 Sep;70(9):4841-50. doi: 10.1128/IAI.70.9.4841-4850.2002. Infect Immun. 2002. PMID: 12183528 Free PMC article.
References
- Science. 1994 Aug 5;265(5173):808-11 - PubMed
- Science. 1993 Mar 19;259(5102):1760-3 - PubMed
- EMBO J. 1994 Oct 3;13(19):4597-607 - PubMed
- Cell. 1989 Jul 28;58(2):227-9 - PubMed
- Cell. 1995 Jan 27;80(2):179-85 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous